Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Hyperoxemia and Oxygen Reserve Index During Neurointerventional Anesthesia

NCT07859982 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-10
Last updated
2026-10-06

Condition(s) studied

HyperoxiaHyperoxemiaCerebrovascular DisordersIntracranial Aneurysms

Investigational drug(s) / intervention(s)

Oxygen Reserve Index Monitoring (Observational)

Oxygen Reserve Index Monitoring (Observational): Non-invasive ORi measurement via multi-wavelength pulse co-oximetry, recorded blinded to the anesthesia team and not used to guide care.

Study summary

The goal of this observational study is to learn how often high blood oxygen levels (hyperoxemia) occur in adults receiving general anesthesia for planned (elective) neurointerventional procedures, such as brain aneurysm coiling or other catheter-based treatments of brain vessels. It will also look at how well a non-invasive finger sensor measurement called the Oxygen Reserve Index (ORi) reflects arterial oxygen levels.

The main questions it aims to answer are:

* How often is the arterial oxygen pressure (PaO2) 150 mmHg or higher in blood gas samples taken as part of routine care during these procedures?
* How does ORi relate to PaO2, and can ORi help identify high oxygen levels?

Participants will:

* Receive anesthesia and their procedure exactly as planned by their care team; the study does not change any treatment, oxygen setting, or ventilator setting.
* Have a painless ORi sensor placed on a finger, similar to a standard pulse oximeter, during anesthesia.
* Have their routine monitoring values and the results of arterial blood gas samples taken for routine clinical care recorded.

No extra blood samples will be taken for the study, and ORi values will not be used to guide care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * American Society of Anesthesiologists (ASA) physical status I-III * Scheduled for an elective neurointerventional procedure * Procedure performed under general anesthesia * Invasive arterial pressure monitoring and arterial blood gas sampling planned as part of routine clinical care * Written informed consent obtained from the patient or, when required, the legal representative Exclusion Criteria: * Refusal to participate * Emergency neurointerventional procedure * ASA physical status IV or higher * Pregnancy * Mechanical ventilation before the procedure * Chronic respiratory failure requiring long-term home oxygen therapy * Severe peripheral circulatory impairment or technical signal failure preventing reliable ORi measurement

Primary outcome measure(s)

  • Proportion of Matched Arterial Blood Gas Measurements With PaO2 >=150 mmHg — Intraoperative period, from intubation to the end of the procedure before FiO2 is increased for emergence (approximately 1-4 hours)
    Number of valid matched ORi-PaO2 measurement pairs with PaO2 \>=150 mmHg divided by the total number of valid matched pairs, multiplied by 100. Only arterial blood gas samples drawn for routine clinical care and matched to a valid ORi value recorded at the time of sampling or within 1 minute are included. Reported with 95% confidence interval.

Trial sites (1)

FacilityCityRegionStatus
University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital Scientific Research Istanbul Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07859982 on ClinicalTrials.gov ↗ ← All trials in Turkey